Yorktown Heights, NY, United States of America

Lisa A Purcell

This inventor holds 16 USPTO granted patents and 6 published patent applications and 1 EPO patent, primarily in Monoclonal Antibodies. Top assignees: Regeneron Pharmaceuticals, Inc., University Health Network. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lisa A Purcell. Retrieved from https://idiyas.com/inventor/lisa-a-purcell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 93.8

 

Average Co-Inventor Count = 1.9

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Garnerville, NY (US) (2018 - 2024)
  • Yorktown Heights, NY (US) (2022 - 2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-PfRH5 Antibodies
Anti-TMPRSS2 Antibodies
Humanized TMPRSS Gene
Cerebral Malaria Treatments
Influenza Hemagglutinin
Vaccine Efficacy
IL-4R Antagonist
Antigen-Binding Fragments
Rodents
Human Antibodies
Antibody Interventions
16 patents (USPTO):Explore Patents

Title: The Innovations of Lisa A. Purcell: Pioneering Antibody Development

Introduction: Lisa A. Purcell, an accomplished inventor located in Yorktown Heights, NY, has made significant contributions to the field of biomedical research. With a total of 16 patents to her name, Purcell is at the forefront of innovative solutions aimed at combating infectious diseases. Her work focuses on the development of antibodies that target specific proteins associated with various infections, notably malaria and viral pathogens.

Latest Patents: Among her most recent innovations are the patents for Anti-PfRH5 antibodies and antigen-binding fragments. This invention encompasses antibodies that specifically bind to reticulocyte binding protein homologue 5 (PfRH5) and includes methods for treating, preventing, or diagnosing malaria. Additionally, she has developed Anti-TMPRSS2 antibodies and antigen-binding fragments, aimed at preventing and treating viral infections, such as those caused by the influenza virus.

Career Highlights: Purcell has an impressive background in the pharmaceutical and research landscape. She has worked with Regeneron Pharmaceuticals, Inc. and the University Health Network, where her expertise has greatly contributed to advancements in therapeutic antibody development. Her strong focus on research and innovation has garnered her recognition in the scientific community.

Collaborations: Throughout her career, Lisa A. Purcell has collaborated with several notable researchers, including Alexander O. Mujica and Yajun Tang. These collaborations have enhanced her work, leading to the development of cutting-edge therapies that hold potential for making profound impacts on public health.

Conclusion: Lisa A. Purcell exemplifies the spirit of innovation in the biomedical field. Her dedication to discovering novel therapeutic solutions for infectious diseases, coupled with her successful patent portfolio, establishes her as a key figure in the realm of antibody research. As she continues to advance her groundbreaking work, the potential for her contributions to save lives and improve health outcomes remains significant.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…